These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Inhaled corticosteroid use and asthma hospitalization rates in Japan. Odajima Y, Kuwabara H. J Int Med Res; 2006; 34(2):208-14. PubMed ID: 16749417 [Abstract] [Full Text] [Related]
6. Inhaled corticosteroid prescribing from the emergency department for children with asthma. Shedd GC, Evans DD. Adv Emerg Nurs J; 2012; 34(4):290-9. PubMed ID: 23111303 [Abstract] [Full Text] [Related]
7. What does potency actually mean for inhaled corticosteroids? Williams DM. J Asthma; 2005; 42(6):409-17. PubMed ID: 16293535 [No Abstract] [Full Text] [Related]
16. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial). Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening A, Haahtela T, Holgate ST, Picado C, Leff JA. Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768 [Abstract] [Full Text] [Related]
17. An update on the safety of long-acting beta-agonists in asthma patients using inhaled corticosteroids. Salpeter SR. Expert Opin Drug Saf; 2010 May; 9(3):407-19. PubMed ID: 20408768 [Abstract] [Full Text] [Related]
18. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids. Friedman HS, Yawn BP. Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696 [Abstract] [Full Text] [Related]